[Belatacept, a new original molecule, immunosuppressive, in organ transplantation].
Beaudreuil
Séverine
S
Durrbach
Antoine
A
Kriaa
Faycal
F
Charpentier
Bernard
B
D000069594:Abatacept; D018122:B7-1 Antigen / Q000187:drug effects / Q000502:physiology; D051940:B7-2 Antigen / Q000502:physiology; D018106:CD28 Antigens / Q000502:physiology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006084:Graft Rejection / Q000517:prevention & control; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D018796:Immunoconjugates / Q000494:pharmacology / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D008958:Models, Molecular; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D016032:Randomized Controlled Trials as Topic; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D014181:Transplantation Immunology / Q000187:drug effects*
D018122:B7-1 Antigen; D051940:B7-2 Antigen; D018106:CD28 Antigens; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept